COVID-19 and breast cancer: may the microbiome be the issue?
作者信息
Lasagna Angioletta, Zuccaro Valentina, Ferraris Elisa, Corbella Marta, Bruno Raffaele, Pedrazzoli Paolo
机构信息
Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, 27100, Pavia, Italy.
Division of Infectious Diseases I, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, 27100, Pavia, Italy.
出版信息
Future Oncol. 2021 Jan;17(2):123-126. doi: 10.2217/fon-2020-0764. Epub 2020 Nov 27.
Abstract
摘要
相似文献
1
COVID-19 and breast cancer: may the microbiome be the issue?
Future Oncol. 2021 Jan;17(2):123-126. doi: 10.2217/fon-2020-0764. Epub 2020 Nov 27.
2
Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19.
Sci China Life Sci. 2021 Jun;64(6):942-956. doi: 10.1007/s11427-020-1847-7. Epub 2021 Jan 27.
3
From Gut to Hormones: Unraveling the Role of Gut Microbiota in (Phyto)Estrogen Modulation in Health and Disease.
Mol Nutr Food Res. 2024 Mar;68(6):e2300688. doi: 10.1002/mnfr.202300688. Epub 2024 Feb 11.
4
The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2.
Trends Mol Med. 2021 Dec;27(12):1115-1134. doi: 10.1016/j.molmed.2021.09.009. Epub 2021 Oct 6.
5
The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.
J Natl Cancer Inst. 2016 Apr 22;108(8). doi: 10.1093/jnci/djw029. Print 2016 Aug.
6
Breast Cancer and Its Relationship with the Microbiota.
Int J Environ Res Public Health. 2018 Aug 14;15(8):1747. doi: 10.3390/ijerph15081747.
7
Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.
NPJ Biofilms Microbiomes. 2021 Jul 22;7(1):61. doi: 10.1038/s41522-021-00232-5.
8
The Microbiome-Estrogen Connection and Breast Cancer Risk.
Cells. 2019 Dec 15;8(12):1642. doi: 10.3390/cells8121642.
9
Gastrointestinal microbiome and breast cancer: correlations, mechanisms and potential clinical implications.
Breast Cancer. 2017 Mar;24(2):220-228. doi: 10.1007/s12282-016-0734-z. Epub 2016 Oct 5.
10
Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?
Gastroenterology. 2022 Jan;162(1):9-16. doi: 10.1053/j.gastro.2021.09.009. Epub 2021 Sep 8.
引用本文的文献
1
Effects of gut microbiota in breast cancer.
Front Oncol. 2025 Jun 17;15:1617410. doi: 10.3389/fonc.2025.1617410. eCollection 2025.
2
Mitigation strategies for gastrointestinal (GI) immune-related adverse events for patients with solid tumors receiving immunotherapy.
Immunotherapy. 2025 Jun;17(8):595-603. doi: 10.1080/1750743X.2025.2516995. Epub 2025 Jun 6.
3
SARS-CoV-2 Infection Risk and COVID-19 Prevalence and Mortality in Cancer Patients During the First Wave of COVID-19 Pandemic in a Virus Epicenter in Northern Italy.
Cancers (Basel). 2025 May 1;17(9):1536. doi: 10.3390/cancers17091536.
4
SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms.
Int J Mol Sci. 2024 Nov 10;25(22):12079. doi: 10.3390/ijms252212079.
5
Changes in the fecal microbiota of breast cancer patients based on 16S rRNA gene sequencing: a systematic review and meta-analysis.
Clin Transl Oncol. 2024 Jun;26(6):1480-1496. doi: 10.1007/s12094-023-03373-5. Epub 2024 Jan 13.
6
Health-related quality of life and patient-centred outcomes with COVID-19 vaccination in patients with breast cancer and gynaecological malignancies.
Front Oncol. 2023 Oct 12;13:1217805. doi: 10.3389/fonc.2023.1217805. eCollection 2023.
7
Relative Risk of Death in Bulgarian Cancer Patients during the Initial Waves of the COVID-19 Pandemic.
Healthcare (Basel). 2023 Sep 20;11(18):2594. doi: 10.3390/healthcare11182594.
8
Gender Differences in Response to COVID-19 Infection and Vaccination.
Biomedicines. 2023 Jun 9;11(6):1677. doi: 10.3390/biomedicines11061677.
9
Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney disease.
Front Immunol. 2023 Mar 21;14:961642. doi: 10.3389/fimmu.2023.961642. eCollection 2023.
10
Long-COVID in Patients with Cancer Previously Treated with Early Anti-SARS-CoV-2 Therapies in an Out-of-Hospital Setting: A Single-Center Experience.
Cancers (Basel). 2023 Feb 16;15(4):1269. doi: 10.3390/cancers15041269.
Zotero 插件